Beam Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Beam Therapeutics Inc. has issued its 2026 proxy statement, outlining the agenda for its upcoming annual meeting of stockholders to be held on June 3, 2026.
NASDAQ
Beam Therapeutics will hold its annual stockholder meeting virtually on June 5, 2024.
NASDAQ
Beam Therapeutics will hold its 2025 annual meeting of stockholders virtually on June 4, 2025, to elect directors, ratify the appointment of its accounting firm, and approve executive compensation.
NASDAQ
Beam Therapeutics will hold its annual stockholder meeting virtually on June 5, 2024, to vote on director election, auditor ratification, and executive compensation.
NASDAQ
Beam Therapeutics will hold its 2024 annual meeting of stockholders virtually on June 5, 2024, to vote on the election of a director, ratification of the independent accounting firm, and executive compensation.